As­traZeneca ex­pands chron­ic kid­ney dis­ease 'Tar­get' cam­paign for Farx­i­ga

In its lat­est com­mer­cial for Farx­i­ga, As­traZeneca prompts peo­ple to ask their doc­tor for their kid­ney num­bers. But what does that mean? It’s a pa­tient-friend­ly way to de­scribe eGFR or uACR test­ing that helps de­ter­mine kid­ney func­tion, said Sarah Wal­ters, VP of car­dio­vas­cu­lar, re­nal and meta­bol­ic dis­eases at As­traZeneca.

She added, “We’re ty­ing to give them some lan­guage that opens up the di­a­logue with physi­cians.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER